Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines

被引:276
作者
Girinsky, Theodore [1 ]
van der Maazen, Richard
Specht, Lena
Aleman, Berthe
Poortmans, Philip
Lievens, Yolande
Meijnders, Paul
Ghalibafian, Mithra
Meerwaldt, Jacobus
Noordijk, Evert
机构
[1] Inst Gustave Roussy, Dept Radiat Oncol, F-94805 Villejuif, France
[2] Dept Radiotherapy, Nijmegen, Netherlands
[3] Copenhagen Univ Hosp, Rigshosp, Finsen Ctr, Copenhagen, Denmark
[4] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands
[5] Dr Bernard Verbeeten Inst, Dept Radiobiol, Tilburg, Netherlands
[6] Radiotherapy Dept, Louvain, Belgium
[7] Dept Radiotherapy, Antwerp, Belgium
[8] Med Spectrum Twente, Dept Radiat Oncol, Enschede, Netherlands
[9] Leiden Univ, Ctr Med, Dept Clin Oncol, Leiden, Netherlands
关键词
Hodgkin lymphoma; involved-node radiotherapy; involved-field radiation treatment; combined modality treatment;
D O I
10.1016/j.radonc.2006.05.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: To describe new concepts for radiation fields in patients with early stage Hodgkin lymphoma treated with a combined modality. Patients and materials: Patients receiving combined modality therapy with at least 2 or 3 cycles of chemotherapy prior to radiotherapy. Pre- and postchemotherapy cervical and thoracic CT scans are mandatory and should be performed, whenever possible, in the treatment position with the use of image fusion capabilities. A pre-chemotherapy PET scan is strongly recommended to increase the detection of involved lymph nodes. Results: Radiation fields are designed to irradiate the initially involved lymph nodes exclusively and to encompass their initial volume. In some cases, radiation fields are slightly modified to avoid unnecessary irradiation of muscles or organs at risk. Conclusions: The concept of involved-node radiotherapy (INRT) described here is the first attempt to reduce the size of radiation fields compared to the classic involved fields used in adult patients. Proper implementation of INRT requires adequate training and an efficient prospective or early retrospective quality assurance program. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:270 / 277
页数:8
相关论文
共 14 条
[1]   Long-term cause-specific mortality of patients treated for Hodgkin's disease [J].
Aleman, BMP ;
van den Belt-Dusebout, AW ;
Klokman, WJ ;
van't Veer, MB ;
Bartelink, H ;
van Leeuwen, FE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3431-3439
[2]  
[Anonymous], 1993, 50 ICRU
[3]   Breast cancer and other second neoplasms after childhood Hodgkin's disease [J].
Bhatia, S ;
Robison, LL ;
Oberlin, O ;
Greenberg, M ;
Bunin, G ;
FossatiBellani, F ;
Meadows, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :745-751
[4]   A REANALYSIS OF AVAILABLE DOSE-RESPONSE AND TIME-DOSE DATA IN HODGKINS-DISEASE [J].
BRINCKER, H ;
BENTZEN, SM .
RADIOTHERAPY AND ONCOLOGY, 1994, 30 (03) :227-230
[5]  
DIEHL V, 2005, J CLIN ONCOL, V23, pS16
[6]   Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group [J].
Engert, A ;
Schiller, P ;
Josting, A ;
Herrmann, R ;
Koch, P ;
Sieber, M ;
Boissevain, F ;
de Wit, M ;
Mezger, J ;
Dühmke, E ;
Willich, N ;
Müller, RP ;
Schmidt, BF ;
Renner, H ;
Müller-Hermelink, HK ;
Pfistner, B ;
Wolf, J ;
Hasenclever, D ;
Löffler, M ;
Diehl, V .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3601-3608
[7]  
Fermé C, 2000, BLOOD, V96, p576A
[8]   FACTORS AFFECTING LATE MORTALITY FROM HEART-DISEASE AFTER TREATMENT OF HODGKINS-DISEASE [J].
HANCOCK, SL ;
TUCKER, MA ;
HOPPE, RT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (16) :1949-1955
[9]   Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: Cure balanced against complications [J].
Koontz, BF ;
Kirkpatrick, JP ;
Clough, RW ;
Prosnitz, RG ;
Gockerman, JP ;
Moore, JO ;
Prosnitz, LR .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) :605-611
[10]   2ND MALIGNANCIES AFTER CURATIVE RADIATION-THERAPY FOR GOOD PROGNOSIS CANCERS [J].
MAUCH, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (04) :959-960